Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Ekblond

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Communications Medicine|December 10, 2022
Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patientsCharlotte Duch Lynggaard, Rosa Jersie-Christensen, Morten Juhl, et al.
Stem Cells International|May 17, 2018
Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial InfarctionBjarke Follin, Adam Ali Ghotbi, Andreas Ettrup Clemmensen, et al.
Stem Cells Translational Medicine|September 8, 2017
Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety StudyJens Kastrup, Mandana Haack-Sørensen, Morten Juhl, et al.
Stem Cells International|January 16, 2018
Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled StudyAbbas Ali Qayyum, Anders Bruun Mathiasen, Naja Dam Mygind, et al.
Trials|September 1, 2023
Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II studyKathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, Christian Grønhøj, et al.
Stem Cells International|October 24, 2017
Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre StudyJens Kastrup, Morten Schou, Ida Gustafsson, et al.
Stem Cells Translational Medicine|April 18, 2022
Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II)Charlotte Duch Lynggaard, Christian Grønhøj, Robin Christensen, et al.
ESC Heart Failure|January 13, 2023
Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failureAbbas Ali Qayyum, Mette Mouridsen, Brian Nilsson, et al.
JHLT Open|April 18, 2025
Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantationAbbas Ali Qayyum, Thomas Kromann Lund, Pia Bredahl Jensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2024
Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled TrialKathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, Tobias Todsen, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Communications Medicine|December 10, 2022
Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patientsCharlotte Duch Lynggaard, Rosa Jersie-Christensen, Morten Juhl, et al.
Stem Cells International|May 17, 2018
Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial InfarctionBjarke Follin, Adam Ali Ghotbi, Andreas Ettrup Clemmensen, et al.
Stem Cells Translational Medicine|September 8, 2017
Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety StudyJens Kastrup, Mandana Haack-Sørensen, Morten Juhl, et al.
Stem Cells International|January 16, 2018
Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled StudyAbbas Ali Qayyum, Anders Bruun Mathiasen, Naja Dam Mygind, et al.
Trials|September 1, 2023
Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II studyKathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, Christian Grønhøj, et al.
Stem Cells International|October 24, 2017
Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre StudyJens Kastrup, Morten Schou, Ida Gustafsson, et al.
Stem Cells Translational Medicine|April 18, 2022
Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II)Charlotte Duch Lynggaard, Christian Grønhøj, Robin Christensen, et al.
ESC Heart Failure|January 13, 2023
Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failureAbbas Ali Qayyum, Mette Mouridsen, Brian Nilsson, et al.
JHLT Open|April 18, 2025
Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantationAbbas Ali Qayyum, Thomas Kromann Lund, Pia Bredahl Jensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2024
Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled TrialKathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, Tobias Todsen, et al.
Pageof 6